Related Experiment Video
Updated: Sep 29, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Suppressive Effect of Autocrine FGF21 on Autophagy-Deficient Hepatic Tumorigenesis
Jinyoung Kim1, Soyeon Lee1,2, Myung-Shik Lee1,3,4
1Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
Abstract:
Mice with hepatocyte-specific deletion of autophagy-related 7 (Atg7 ΔHep mice) develop hepatoma, suggesting that autophagy deficiency could be a factor in the initiation of tumorigenesis. We have shown that FGF21 is induced as a 'mitokine' when Atg7 is disrupted in insulin target tissues such as the liver, which could affect systemic metabolism through endocrine activity. Since FGF21 or other endocrine FGF such as FGF19 can affect tumor growth, we hypothesized that FGF21 produced by Atg7-knockout (KO) hepatocytes may affect the behavior of Atg7-KO hepatoma in an autocrine manner. We, thus, crossed Atg7 ΔHep mice with systemic Fgf21-KO (Fgf21 -/-) mice to generate Atg7 ΔHep Fgf21 -/- mice. The number and size of hepatoma of Atg7 ΔHep mice were significantly increased by additional Fgf21 KO. The proliferation of Atg7-KO hepatocyte was significantly increased by Fgf21 KO. pYAP1/YAP1 representing YAP1 degradation was significantly decreased in the liver of Atg7 ΔHep Fgf21 -/- mice compared to Atg7 ΔHep Fgf21 +/+ mice. Consistently, expression of YAP1/TAZ downstream genes was significantly increased in the liver of Atg7 ΔHep Fgf21 -/- mice compared to Atg7 ΔHep Fgf21 +/+ mice, which could explain the increased size of hepatoma in Atg7 ΔHep Fgf21 -/- mice. Accumulation of ROS and ROS-mediated DNA damage were increased in the liver of Atg7 ΔHep Fgf21 +/+ mice, which was further aggravated by additional Fgf21 KO probably due to the absence of positive effect of FGF21 on mitochondrial function, explaining the increased number of hepatoma in Atg7 ΔHep Fgf21 -/- mice compared to Atg7 ΔHep Fgf21 +/+ mice. These results show that FGF21 produced by autophagy-deficient hepatocytes could have autocrine or paracrine effects on the number and proliferation of autophagy-deficient hepatoma, suggesting that hormones or factors released from autophagy-deficient tumors can influence the behavior or prognosis of the tumor in addition to the effects on host metabolism.
Insights
Autophagy deficiency in liver cells promotes hepatoma. Fibroblast growth factor 21 (FGF21) produced by these cells accelerates tumor growth by increasing cell proliferation and DNA damage, worsening prognosis.
Area of Science:
- Cell Biology
- Oncology
- Metabolism
Background:
- Autophagy is crucial for cellular health; its deficiency, specifically in hepatocytes (liver cells), is linked to hepatoma development.
- Fibroblast growth factor 21 (FGF21), a 'mitokine,' is upregulated when autophagy-related 7 (Atg7) is disrupted in liver tissues, potentially influencing systemic metabolism.
- FGF21 and related FGFs are known to impact tumor progression, suggesting a role in autophagy-deficient hepatoma.
Purpose of the Study:
- To investigate the autocrine effect of FGF21 produced by Atg7-knockout (KO) hepatocytes on the behavior of autophagy-deficient hepatoma.
- To determine how FGF21 influences hepatoma proliferation, size, and number in a genetic model of autophagy deficiency.
Main Methods:
- Generation of Atg7 ΔHep Fgf21 -/- mice by crossing Atg7 ΔHep mice with systemic Fgf21-KO mice.
- Analysis of hepatoma number, size, and hepatocyte proliferation in Atg7 ΔHep mice with and without Fgf21 KO.
- Assessment of YAP1 degradation, YAP1/TAZ downstream gene expression, reactive oxygen species (ROS) accumulation, and ROS-mediated DNA damage in the liver.
Main Results:
- Hepatoma number and size were significantly increased in Atg7 ΔHep mice lacking Fgf21 (Atg7 ΔHep Fgf21 -/-) compared to those with intact Fgf21 (Atg7 ΔHep Fgf21 +/+).
- Hepatocyte proliferation was significantly elevated in Atg7-KO hepatocytes when Fgf21 was absent.
- YAP1 degradation decreased, YAP1/TAZ gene expression increased, and ROS-mediated DNA damage was aggravated in Atg7 ΔHep Fgf21 -/- mice, correlating with increased hepatoma size and number.
Conclusions:
- FGF21 produced by autophagy-deficient hepatocytes exerts autocrine or paracrine effects that influence the proliferation and number of autophagy-deficient hepatoma.
- Factors released from autophagy-deficient tumors, such as FGF21, can modulate tumor behavior and prognosis, extending beyond their impact on host metabolism.
- Targeting FGF21 signaling may offer a therapeutic strategy for managing hepatoma associated with autophagy deficiency.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Abnormal Proliferation
Mitogens and the Cell Cycle
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
TGF - β Signaling Pathway

